TENET HEALTHCARE CORP (THC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 8B 16B 24B Q4 '17: 20.2B Q1 '18: 20.1B Q2 '18: 19.4B Q3 '18: 19B Q4 '18: 18.3B Q1 '19: 18.2B Q2 '19: 18.2B Q3 '19: 18.3B Q4 '19: 18.5B Q1 '20: 18.5B Q2 '20: 17.5B Q3 '20: 17.5B Q4 '20: 17.6B Q1 '21: 17.9B Q2 '21: 19.2B Q3 '21: 19.5B Q4 '21: 19.5B Q1 '22: 19.4B Q2 '22: 19.1B Q3 '22: 19B Q4 '22: 19.2B Q1 '23: 19.4B Q2 '23: 19.9B Q3 '23: 20.2B Q4 '23: 20.6B Q1 '24: 20.9B Q2 '24: 20.9B Q3 '24: 21B Q4 '24: 20.7B Q1 '25: 15.3B Q2 '25: 10.2B Q3 '25: 10.4B Q4 '25: 10.8B Q1 '26: 11.2B Q2 '26: 11.6B Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

0 2.5B 5B 7.5B Q4 '09: 538M Q1 '10: 563M Q2 '10: 596M Q3 '10: 560M Q4 '10: 634M Q1 '11: 692M Q2 '11: 686M Q3 '11: 668M Q4 '11: 658M Q1 '12: 604M Q2 '12: 619M Q3 '12: 693M Q4 '12: 749M Q1 '13: 690M Q2 '13: 712M Q3 '13: 707M Q4 '13: 663M Q1 '14: 687M Q2 '14: 692M Q3 '14: 755M Q4 '14: 925M Q1 '15: 1B Q2 '15: 1B Q3 '15: 1.1B Q4 '15: 1.1B Q1 '16: 1.1B Q2 '16: 1.3B Q3 '16: 1.3B Q4 '16: 1.2B Q1 '17: 1.2B Q2 '17: 1.2B Q3 '17: 908M Q4 '17: 1.1B Q1 '18: 1.4B Q2 '18: 1.5B Q3 '18: 1.7B Q4 '18: 1.6B Q1 '19: 1.5B Q2 '19: 1.5B Q3 '19: 1.5B Q4 '19: 1.5B Q1 '20: 1.5B Q2 '20: 1.6B Q3 '20: 1.5B Q4 '20: 2B Q1 '21: 2.2B Q2 '21: 2.3B Q3 '21: 3B Q4 '21: 2.9B Q1 '22: 3B Q2 '22: 3B Q3 '22: 2.5B Q4 '22: 2.3B Q1 '23: 2.3B Q2 '23: 2.3B Q3 '23: 2.3B Q4 '23: 2.5B Q1 '24: 5.2B Q2 '24: 5.3B Q3 '24: 5.9B Q4 '24: 6B Q1 '25: 3.6B Q2 '25: 3.7B Q3 '25: 3.5B Q4 '25: 3.5B Q1 '26: 3.9B Q2 '26: 4.5B Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Net Income TTM

-1.5B 0 1.5B 3B 4.5B Q1 '10: 91M Q2 '10: 131M Q3 '10: 1.1B Q4 '10: 1.1B Q1 '11: 1.1B Q2 '11: 1.1B Q3 '11: 208M Q4 '12: 133M Q1 '13: -17M Q2 '13: -40M Q3 '13: -36M Q4 '13: -114M Q1 '14: -47M Q2 '14: -11M Q3 '14: -29M Q4 '14: 76M Q1 '15: 168M Q2 '15: 147M Q3 '15: 157M Q4 '15: 78M Q1 '16: 36M Q2 '16: 103M Q3 '16: 155M Q4 '16: 176M Q1 '17: 178M Q2 '17: 171M Q3 '17: -198M Q4 '17: -320M Q1 '18: -165M Q2 '18: -89M Q3 '18: 265M Q4 '18: 466M Q1 '19: 347M Q2 '19: 360M Q3 '19: 149M Q4 '19: 171M Q1 '20: 258M Q2 '20: 306M Q3 '20: 346M Q4 '20: 768M Q1 '21: 831M Q2 '21: 919M Q3 '21: 1.6B Q4 '21: 1.5B Q1 '22: 1.5B Q2 '22: 1.5B Q3 '22: 1.1B Q4 '22: 1B Q1 '23: 1B Q2 '23: 1.1B Q3 '23: 1.1B Q4 '23: 1.3B Q1 '24: 3.3B Q2 '24: 3.5B Q3 '24: 3.9B Q4 '24: 4.1B Q1 '25: 2.4B Q2 '25: 2.4B Q3 '25: 2.3B Q4 '25: 2.4B Q1 '26: 2.7B Q2 '26: 3.2B Q2 '11 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

0 1.5B 3B 4.5B Q2 '10: 430M Q3 '10: 438M Q4 '10: 472M Q1 '11: 492M Q2 '11: 479M Q3 '11: 499M Q4 '11: 497M Q1 '12: 457M Q2 '12: 522M Q3 '12: 510M Q4 '12: 593M Q1 '13: 603M Q2 '13: 520M Q3 '13: 590M Q4 '13: 589M Q1 '14: 602M Q2 '14: 708M Q3 '14: 723M Q4 '14: 687M Q1 '15: 649M Q2 '15: 793M Q3 '15: 1.1B Q4 '15: 1B Q1 '16: 1.2B Q2 '16: 1.3B Q3 '16: 1B Q4 '17: 1.2B Q1 '18: 1.1B Q2 '18: 1.3B Q3 '18: 1.3B Q4 '18: 1B Q1 '19: 946M Q2 '19: 882M Q3 '19: 963M Q4 '19: 1.2B Q1 '20: 1.4B Q2 '20: 3.3B Q3 '20: 3.5B Q4 '20: 3.4B Q1 '21: 3.8B Q2 '21: 1.8B Q3 '21: 1.7B Q4 '21: 1.6B Q1 '22: 1.3B Q2 '22: 1.1B Q3 '22: 1B Q4 '22: 1.1B Q1 '23: 1.3B Q2 '23: 1.8B Q3 '23: 2B Q4 '23: 2.4B Q1 '24: 2.5B Q2 '24: 2.7B Q3 '24: 3.2B Q4 '25: 3.5B Q1 '26: 4.4B Q2 '26: 4B Q2 '10 Q2 '12 Q2 '14 Q2 '16 Q2 '19 Q2 '21 Q2 '23 Q2 '26

Free Cash Flow TTM

-1.5B 0 1.5B 3B 4.5B Q4 '12: 440M Q1 '13: 319M Q2 '13: 114M Q3 '13: 44M Q4 '13: -102M Q1 '14: -237M Q2 '14: -250M Q3 '14: -304M Q4 '14: -246M Q1 '15: -187M Q2 '15: 24M Q3 '15: 289M Q4 '15: 184M Q1 '16: 364M Q2 '16: 359M Q3 '16: 152M Q4 '17: 493M Q1 '18: 475M Q2 '18: 633M Q3 '18: 671M Q4 '18: 432M Q1 '19: 280M Q2 '19: 197M Q3 '19: 258M Q4 '19: 563M Q1 '20: 692M Q2 '20: 2.7B Q3 '20: 2.9B Q4 '20: 2.9B Q1 '21: 3.3B Q2 '21: 1.3B Q3 '21: 1.1B Q4 '21: 910M Q1 '22: 570M Q2 '22: 414M Q3 '22: 243M Q4 '22: 321M Q1 '23: 462M Q2 '23: 961M Q3 '23: 1.1B Q4 '23: 1.6B Q1 '24: 1.8B Q2 '24: 1.9B Q3 '24: 2.4B Q4 '25: 2.5B Q1 '26: 3.3B Q2 '26: 3B Q4 '13 Q2 '15 Q4 '17 Q2 '19 Q4 '20 Q2 '22 Q4 '23 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 200M 400M 600M Q2 '09: 488.2M Q3 '09: 498.1M Q1 '10: 559.2M Q2 '10: 502.5M Q3 '10: 559.9M Q1 '11: 565.2M Q2 '11: 503.7M Q3 '11: 120.9M Q1 '12: 121.2M Q2 '12: 106.9M Q3 '12: 107.3M Q1 '13: 104.1M Q2 '13: 103M Q3 '13: 103.1M Q1 '14: 97.2M Q2 '14: 97.7M Q3 '14: 100.9M Q1 '15: 100.9M Q2 '15: 99.2M Q3 '15: 99.5M Q1 '16: 98.8M Q2 '16: 99.3M Q3 '16: 99.5M Q1 '17: 100M Q2 '17: 100.6M Q3 '17: 100.8M Q1 '18: 102.7M Q2 '18: 104.2M Q3 '18: 102.4M Q1 '19: 102.8M Q2 '19: 104.6M Q3 '19: 103.6M Q1 '20: 105.7M Q2 '20: 105.6M Q3 '20: 105.3M Q1 '21: 108.1M Q2 '21: 108.6M Q3 '21: 108.8M Q1 '22: 112M Q2 '22: 108.8M Q3 '22: 109.9M Q1 '23: 106M Q2 '23: 104.8M Q3 '23: 104.4M Q1 '24: 100.6M Q2 '24: 98.4M Q3 '24: 96.7M Q1 '25: 95M Q2 '25: 91.8M Q3 '25: 88.6M Q1 '26: 87.6M Q2 '26: 84M Q1 '10 Q2 '12 Q3 '14 Q1 '17 Q2 '19 Q3 '21 Q1 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 0.00 15.00 30.00 45.00 Q1 '10: 0.17 Q2 '10: 0.25 Q3 '10: 1.94 Q4 '10: 8.16 Q1 '11: 8.13 Q2 '11: 8.19 Q3 '11: 6.56 Q4 '11: 0.48 Q1 '12: 0.87 Q2 '13: -0.53 Q3 '13: -0.63 Q4 '13: -1.32 Q1 '14: -0.80 Q2 '15: 0.58 Q3 '15: 0.20 Q4 '15: -1.41 Q1 '16: -2.48 Q2 '16: -2.33 Q3 '17: -5.51 Q4 '17: -6.99 Q1 '18: -5.50 Q2 '20: -0.50 Q3 '20: -0.18 Q4 '20: 3.71 Q1 '21: 3.73 Q2 '21: 4.00 Q3 '21: 9.99 Q4 '21: 8.42 Q1 '22: 8.80 Q2 '23: 4.60 Q3 '23: 4.38 Q4 '23: 5.71 Q1 '24: 25.77 Q2 '24: 27.26 Q3 '24: 31.21 Q4 '24: 32.34 Q1 '25: 15.23 Q2 '25: 15.73 Q3 '25: 14.70 Q4 '25: 15.48 Q1 '26: 19.22 Q2 '26: 25.92 Q2 '11 Q4 '13 Q2 '16 Q4 '20 Q2 '23 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.